Decision makers' views on health care objectives and budget constraints: results from a pilot study
- PMID: 15312708
- DOI: 10.1016/j.healthpol.2004.01.009
Decision makers' views on health care objectives and budget constraints: results from a pilot study
Erratum in
- Health Policy. 2005 Sep 28;74(1):111
Abstract
Economic evaluations aim to inform policy makers about the costs and effects of medical interventions to support their decisions on the allocation of health care resources. Decision makers combine information on cost-effectiveness with their preferences and with possible constraints for the allocation of health care resources. That is, decision makers need to specify an optimality criterion and all possible (budget) constraints. Usually this is a more or less implicit process. The aim of our pilot study was to find out whether decision makers consider the objectives and budget constraints we selected for a theoretical model of resource allocation relevant, and to set priorities for these objectives.
Similar articles
-
Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.Health Policy. 2005 Oct;74(2):146-56. doi: 10.1016/j.healthpol.2004.12.015. Epub 2005 Jan 26. Health Policy. 2005. PMID: 16153475
-
Finding legitimacy for the role of budget impact in drug reimbursement decisions.Int J Technol Assess Health Care. 2009 Jan;25(1):49-55. doi: 10.1017/S0266462309090072. Int J Technol Assess Health Care. 2009. PMID: 19126251
-
Generalised cost-effectiveness analysis: an aid to decision making in health.Appl Health Econ Health Policy. 2002;1(2):89-95. Appl Health Econ Health Policy. 2002. PMID: 14619255 Review.
-
Role of budget impact in drug reimbursement decisions.J Health Polit Policy Law. 2008 Apr;33(2):225-47. doi: 10.1215/03616878-2007-054. J Health Polit Policy Law. 2008. PMID: 18325899
-
Health economic research on vaccinations and immunisation practices--an introductory primer.Vaccine. 2005 Mar 18;23(17-18):2095-103. doi: 10.1016/j.vaccine.2005.01.064. Vaccine. 2005. PMID: 15755578 Review.
Cited by
-
Public funding of pharmaceuticals in The Netherlands: investigating the effect of evidence, process and context on CVZ decision-making.Eur J Health Econ. 2014 Sep;15(7):681-95. doi: 10.1007/s10198-013-0514-z. Epub 2013 Jul 18. Eur J Health Econ. 2014. PMID: 23864365
-
Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.Osteoporos Int. 2010 Jan;21(1):157-65. doi: 10.1007/s00198-009-0924-z. Epub 2009 Apr 7. Osteoporos Int. 2010. PMID: 19350339 Clinical Trial.
-
Bridging the gap between health and non-health investments: moving from cost-effectiveness analysis to a return on investment approach across sectors of economy.Int J Health Care Finance Econ. 2008 Jun;8(2):113-21. doi: 10.1007/s10754-008-9032-4. Epub 2008 Mar 20. Int J Health Care Finance Econ. 2008. PMID: 18351456
-
Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review.Pharmacoeconomics. 2018 Mar;36(3):323-340. doi: 10.1007/s40273-017-0586-1. Pharmacoeconomics. 2018. PMID: 29124632
-
The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada.Cost Eff Resour Alloc. 2013 May 20;11(1):11. doi: 10.1186/1478-7547-11-11. Cost Eff Resour Alloc. 2013. PMID: 23688138 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical